Octopath AI Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.33M

  • Investors
  • 3

Octopath AI General Information

Description

Developer of an artificial intelligence platform designed to automate cancer pathology and tissue analysis. The company offers the kraken cell classification model, the Nemo immunohistochemistry analysis tool, a digital pathology research platform, automated mitosis detection software, immune cell mapping tools, and biomarker scoring systems, enabling pathology services to identify patient subgroups with differing treatment outcomes and generate quantitative evidence for targeted treatment research from routine tissue specimens.

Contact Information

Website
www.octopath.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • London
  • England, United Kingdom
Primary Industry
Decision/Risk Analysis
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • London
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Octopath AI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 03-Nov-2026 $1.33M Completed Generating Revenue
2. Grant Completed Generating Revenue
1. University Spin-Out 01-Jan-2026 Completed Generating Revenue
To view Octopath AI’s complete valuation and funding history, request access »

Octopath AI Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
To view Octopath AI’s complete cap table history, request access »

Octopath AI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Octopath AI Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Twin Path Ventures Venture Capital Minority
University College London University
Innovate UK Government
To view Octopath AI’s complete investors history, request access »

Ready to get started?

Request a free trial

Octopath AI FAQs

  • When was Octopath AI founded?

    Octopath AI was founded in 2026.

  • Where is Octopath AI headquartered?

    Octopath AI is headquartered in London, United Kingdom.

  • What is the size of Octopath AI?

    Octopath AI has 6 total employees.

  • What industry is Octopath AI in?

    Octopath AI’s primary industry is Decision/Risk Analysis.

  • Is Octopath AI a private or public company?

    Octopath AI is a Private company.

  • What is the current valuation of Octopath AI?

    The current valuation of Octopath AI is .

  • What is Octopath AI’s current revenue?

    The current revenue for Octopath AI is .

  • How much funding has Octopath AI raised over time?

    Octopath AI has raised $1.33M.

  • Who are Octopath AI’s investors?

    Twin Path Ventures, University College London, and Innovate UK have invested in Octopath AI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process